ClinicalTrials.Veeva
Menu

Find clinical trials for Eczema in San Diego, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Atopic Dermatitis
Dermatitis
Skin Diseases
Immune System Diseases
Eczematous Skin Diseases
Pruritus
Food Hypersensitivity

Eczema trials near San Diego, CA, USA:

Locations recently updated

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

This research study is being conducted to find out if the test medicine, abrocitinib, improves eczema and is safe for children 6 to \<12 yea...

Enrolling
Eczema
Drug: Abrocitinib
Other: Placebo

Phase 3

Pfizer
Pfizer

San Diego, California, United States and 46 other locations

Locations recently updated

This 24-month study will assess the long-term safety and efficacy of liquid abrocitinib oral suspension with or without topical medications in childr...

Enrolling
Atopic Dermatitis
Drug: Abrocitinib

Phase 3

Pfizer
Pfizer

San Diego, California, United States and 38 other locations

The purpose of this global Phase 3 clinical study is to investigate the safety and efficacy of tapinarof cream, 1% in participants ages 3 months to 2...

Active, not recruiting
Atopic Dermatitis
Drug: Vehicle Cream
Drug: Tapinarof cream, 1%

Phase 3

Organon
Organon

San Diego, California, United States of America and 47 other locations

The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema ...

Active, not recruiting
Atopic Dermatitis
Drug: Lebrikizumab

Phase 4

Lilly
Lilly

Encinitas, California, United States of America and 71 other locations

The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18...

Active, not recruiting
Eczema
Atopic Dermatitis
Drug: Placebo
Drug: Lebrikizumab

Phase 3

Lilly
Lilly

San Diego, California, United States and 89 other locations

The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD.The secondary objectives of the s...

Active, not recruiting
Atopic Dermatitis
Drug: Dupilumab

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

San Diego, California, United States and 83 other locations

This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.

Active, not recruiting
Eczema
Atopic Dermatitis
Drug: ATI-045
Drug: Placebo

Phase 2

Aclaris Therapeutics
Aclaris Therapeutics

Encinitas, California, United States and 60 other locations

This is a Phase 1b, randomized, placebo/vehicle-controlled, double-blinded, multi-center trial. It is designed to assess the safety and efficacy of S...

Enrolling
Atopic Dermatitis
Drug: Fluocinonide Ointment
Drug: Clobetasol Ointment

Phase 1

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

San Diego, California, United States and 7 other locations

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with Atopic Dermatitis

Active, not recruiting
Atopic Dermatitis
Biological: Barzolvolimab
Drug: Matching placebo

Phase 2

Celldex Therapeutics
Celldex Therapeutics

San Diego, California, United States and 36 other locations

The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...

Enrolling
Atopic Dermatitis
Drug: PF-07275315
Other: Placebo

Phase 2

Pfizer
Pfizer

San Diego, California, United States and 102 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems